ROBIN LABERGE: Open Payments
NPI 1033542717 · DERRY, NH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,577 in 71 payments from 22 companies in 2025. Trend: 2023 $965 · 2024 $1,146 · 2025 $1,577
Food & beverage: $1,577
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $259 |
| ABBVIE INC. | 15 | $253 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $200 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $151 |
| Lilly USA, LLC | 1 | $105 |
| NeurAxis, Inc. | 1 | $88 |
| GENZYME CORPORATION | 2 | $66 |
| Regeneron Healthcare Solutions, Inc. | 2 | $53 |
| QOL Medical, LLC | 1 | $47 |
| Phathom Pharmaceuticals, Inc. | 4 | $41 |
Products named: TREMFYA, XIFAXAN, ENTYVIO, RINVOQ, DUPIXENT, LINZESS, EOHILIA, Sucraid.
Industry payments across NH — which companies pay providers there.
